(Alliance News) - Shares in Abingdon Health PLC jumped on Tuesday after the firm said that it received initial orders from Vatic Health Ltd for the manufacturing of Vatic KnowNow tests.
Shares were up 19% at 12.20 pence each on Tuesday morning in London.
Vatic KnowNow is a saliva Covid-19 antigen test from London-based diagnostics technology firm Vatic.
York, England-based rapid test developer and manufacturer Abingdon completed the technical transfer of the Vatic KnowNow on behalf of Vatic on schedule.
This followed the conclusion of the scale-up and manufacture of three independent production-scale batches, Abingdon explained.
Vatic subsequently approved tests manufactured by Abingdon and the company received the initial purchase orders from Vatic for commercial sale. The manufacturing of these orders will now start.
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.